{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:15:58Z","timestamp":1760548558397,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ejpb.2023.05.013","type":"journal-article","created":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T22:19:42Z","timestamp":1684361982000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a new age-appropriate, chewable tablet of mebendazole 500\u00a0mg for preventive chemotherapy of soil-transmitted helminth infections in pre-school and school-age children"],"prefix":"10.1016","volume":"188","author":[{"given":"Ben","family":"Van Hove","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pritam","family":"Kanagale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Quinten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheetal","family":"Gaiki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Collignon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh","family":"Swar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimit","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ellen","family":"Verheyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentina-Maria","family":"Preda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asim","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Caporicci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Lequieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Masschelein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Schaufelberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2023.05.013_b0005","unstructured":"WHO Schistosomiasis and soil-transmitted helminthiases: number of people treated in 2018. Wkly Epidemiol Rec. 2019, 50, 601\u2013612."},{"key":"10.1016\/j.ejpb.2023.05.013_b0010","unstructured":"CDC (Center for Disease Control and Prevention) Parasites \u2013 Soil-Transmitted Helminths (STHs) Available online: www.cdc.gov\/parasties\/sth\/ (accessed on Oct 3, 2013)."},{"key":"10.1016\/j.ejpb.2023.05.013_b0015","unstructured":"WHO Soil-transmitted helminth infections - Fact Sheets Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/soil-transmitted-helminth-infections (accessed on Jan 27, 2021)."},{"key":"10.1016\/j.ejpb.2023.05.013_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008505","article-title":"The global progress of soil-transmitted helminthiases control in 2020 and world health organization targets for 2030","volume":"14","author":"Montresor","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2023.05.013_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0009422","article-title":"The role of diagnostic technologies to measure progress toward WHO 2030 targets for soil-transmitted helminth control programs","volume":"15","author":"Stuyver","year":"2021","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2023.05.013_b0030","unstructured":"London Declaration on Neglected Tropical Diseases Available online: https:\/\/www.who.int\/neglected_diseases\/London_Declaration_NTDs.pdf (accessed on Apr 23, 2021)."},{"key":"10.1016\/j.ejpb.2023.05.013_b0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/jphp.12610","article-title":"Evidence of acceptability of oral paediatric medicines: a review","volume":"69","author":"Mistry","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2023.05.013_b0040","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for Industry Orally Disintegrating Tablets. Federal Register 2008."},{"key":"10.1016\/j.ejpb.2023.05.013_b0045","first-page":"1","article-title":"Path towards efficient paediatric formulation development based on partnering with clinical pharmacologists and clinicians, a conect4children expert group white paper","author":"Walsh","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2023.05.013_b0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006578","article-title":"Risk of adverse swallowing events and choking during deworming for preschool-aged children","volume":"12","author":"Kernell","year":"2018","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.ejpb.2023.05.013_b0055","doi-asserted-by":"crossref","first-page":"155","DOI":"10.7324\/JAPS.2020.10718","article-title":"Pediatric dosage forms-challenges and recent developments: a critical review","volume":"10","author":"Galande","year":"2020","journal-title":"J. Appl. Pharm. Sci."},{"year":"2014","series-title":"Pediatric formulations: a roadmap","author":"Bar-Shalom","key":"10.1016\/j.ejpb.2023.05.013_b0060"},{"key":"10.1016\/j.ejpb.2023.05.013_b0065","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2013.10.006","article-title":"Paediatric oral biopharmaceutics: key considerations and current challenges","volume":"73","author":"Batchelor","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2023.05.013_b0070","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1002\/jcph.1138","article-title":"Drug formulations: standards and novel strategies for drug administration in pediatrics","volume":"58","author":"Thabet","year":"2018","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2023.05.013_b0075","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1208\/s12248-013-9511-5","article-title":"report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms","volume":"15","author":"Zajicek","year":"2013","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2023.05.013_b0080","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.addr.2014.02.012","article-title":"Playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients","volume":"73","author":"Walsh","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2023.05.013_b0085","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ijpharm.2015.05.013","article-title":"Formulation factors affecting acceptability of oral medicines in children","volume":"492","author":"Liu","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2023.05.013_b0090","first-page":"712","article-title":"Efficacy of single-dose mebendazole, polymorphic forms A and C, in the treatment of hookworm and Trichuris infections","volume":"24","author":"Charoenlarp","year":"1993","journal-title":"J. Trop. Med. Public Heal."},{"key":"10.1016\/j.ejpb.2023.05.013_b0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpba.2016.01.035","article-title":"Mebendazole crystal forms in tablet formulations. An ATR-FTIR\/chemometrics approach to polymorph assignment","volume":"122","author":"Calvo","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2023.05.013_b0100","first-page":"415","article-title":"Polymorphic forms of mebendazole: analytical aspects and toxicity","author":"Costa","year":"1991","journal-title":"Circ. Farm."},{"key":"10.1016\/j.ejpb.2023.05.013_b0105","first-page":"123","article-title":"Polymorphic forms of mebendazole","volume":"6","author":"Himmelreich","year":"1977","journal-title":"Aust. J. Pharm. Sci."},{"journal-title":"Online","year":"2021","key":"10.1016\/j.ejpb.2023.05.013_b0110"},{"year":"2019","series-title":"Monographs: Pharmaceutical substances: Mebendazole (Mebendazolum)","author":"Who","key":"10.1016\/j.ejpb.2023.05.013_b0115"},{"key":"10.1016\/j.ejpb.2023.05.013_b0120","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jps.21899","article-title":"Characterization of polymorph transformations that decrease the stability of tablets containing the WHO essential drug mebendazole","volume":"99","author":"Brits","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.05.013_b0125","unstructured":"EMA\/CHMP\/CVMP\/QWP\/354895\/2017. Questions and answers: improving the understanding of NORs, PARs, DSp and normal variability of process parameters."},{"key":"10.1016\/j.ejpb.2023.05.013_b0130","first-page":"42306","volume":"83","year":"2018","journal-title":"Federal Register."},{"key":"10.1016\/j.ejpb.2023.05.013_b0135","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.4269\/ajtmh.17-0108","article-title":"Efficacy and safety of a single-dose mebendazole 500 mg chewable, rapidly-disintegrating tablet for ascaris lumbricoides and trichuris trichiura infection treatment in pediatric patients: A double-blind, randomized, placebo-controlled, phase 3 study","volume":"97","author":"Silber","year":"2017","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.ejpb.2023.05.013_b0140","first-page":"27","article-title":"Efficacy, safety and acceptability of a new chewable formulation versus the solid tablet of mebendazole against hookworm infections in children: An open-label, randomized controlled trial","author":"Palmeirim","year":"2020","journal-title":"EClinicalMedicine."},{"key":"10.1016\/j.ejpb.2023.05.013_b0145","unstructured":"WHO Overview of WHO Public Assessment Report (WHOPAR): NT006 - Mebendazole - 500mg - Chewable tablet - Janssen-Cilag International NV - Belgium Available online: https:\/\/extranet.who.int\/pqweb\/WHOPAR\/nt006 (accessed on Apr 23, 2021)."},{"key":"10.1016\/j.ejpb.2023.05.013_b0150","unstructured":"WHO Guidance Document: Notes on the Design of Bioequivalence Study: Mebendazole. Available online: https:\/\/extranet.who.int\/pqweb\/sites\/default\/files\/documents\/BE_Mebendazole_March2023.pdf (accessed Apr 24, 2023)."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123001352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123001352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:53:43Z","timestamp":1760547223000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123001352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":30,"alternative-id":["S0939641123001352"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.05.013","relation":{},"ISSN":["0939-6411"],"issn-type":[{"type":"print","value":"0939-6411"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a new age-appropriate, chewable tablet of mebendazole 500\u00a0mg for preventive chemotherapy of soil-transmitted helminth infections in pre-school and school-age children","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.05.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Janssen Pharmaceutica NV. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}